Paid Clinical Trials in Stamford, CT
As of August 2026, 83 paid clinical trials are recruiting in Stamford, Connecticut. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Stamford offers studies at sites including Smilow Cancer Hospital Care Center at Long Ridge for conditions such as Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Obesity, Stage IV Lung Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Stamford
Trials by drug in Stamford
Filter results
Newly added in Stamford
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
79 clinical trials
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Study of DONQ52 in Active Celiac Disease
A Study of Buntanetap in Participants With PD
Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Study of EVO756 in Adults With Migraine
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
STOP AF First Post-Approval Study
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Top Research Study Locations in Stamford
Researchers run research studies in Stamford, CT at 22 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Smilow Cancer Hospital Care Center at Long Ridge | Anatomic Stage II Breast Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Recurrent Lung Non-Small Cell Carcinoma | 30 |
| Stamford Hospital/Bennett Cancer Center | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Breast Cancer | 11 |
| Stamford Hospital | Breast Cancer, Triple Negative Breast Cancer, Chronic Myelogenous Leukemia - Chronic Phase | 10 |
| Stamford Therapeutics Consortium | Obesity, Overweight, Celiac Disease | 5 |
| Cardiology Associates of Fairfield County | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 3 |
| Ki Health Partners LLC DBA New England Institute for Clinical Research | Chronic Migraine in Children, Episodic Migraine, Migraine | 3 |
| Ki Health Partners, LLc, dba New England Institute for Clinical Research | Acute Treatment of Migraine, Amyloid, Cognitive Dysfunction | 3 |
| Kailera Clinical Site | Obesity, Obesity With Diabetes, Overweight With Diabetes | 2 |
| New England Fertility Institute | Fertility Disorders, Male Infertility, Azoospermia | 2 |
| New England Institute Neurology and Headache, Merz Investigational | Chronic Migraine, Episodic Migraine | 2 |
| Smilow Cancer Hospital - Long Ridge | Breast Cancer, Breast Neoplasms | 2 |
| New England Institute for Clinical Research | Migraine | 2 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| Bariatric and Specialty Surgery Center of Stamford | Pain, Postoperative | 1 |
| Cardiology Associates of Fairfield County PC | Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Obesity | 1 |
| Cardiology Associates of Fairfield County, P.C. | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| Ki Health Partners, LLC | Agitation, Alzheimer's Type Dementia | 1 |
| New England Institute for Clinical Research (Ki Health Partners) | Deep Brain Stimulation, Parkinson's Disease (PD) | 1 |
| New England Institute for Neurology and Headache | Migraine | 1 |
| New England Institute for Neurology and Headache (NEINH)/Medical Practice | Chronic Migraine, Episodic Migraine | 1 |
| Orthopaedic Foundation | Arthritis, Osteo Arthritis of the Knee | 1 |
| The Stamford Health/The Stamford Hospital | Lung Cancer, Pulmonary Nodule, Solitary | 1 |
Active & Upcoming Studies in Stamford (2026)
Recruiting trials in Stamford grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (47 active studies)
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
Neurology & pain (12 active studies)
- Study of EVO756 in Adults With Migraine · Phase 2 · Evommune, Inc.
- Gastrectomy at Low Pressure Trial - (GALPT) · SurgiQuest, Inc.
Diabetes & metabolic (8 active studies)
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes · Phase 3 · Eli Lilly and Company
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
Cardiovascular (6 active studies)
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Pediatric (2 active studies)
- A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine · Phase 3 · H. Lundbeck A/S
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Common conditions studied in Stamford
- Breast Cancer (6 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (5 active studies)
- Obesity (5 active studies)
- Stage IV Lung Cancer AJCC v8 (5 active studies)
- Migraine (4 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (3 active studies)
Leading research sponsors in Stamford
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Eli Lilly and Company
- NRG Oncology
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Stamford?
There are approximately 83 recruiting clinical trials in Stamford, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Stamford pay participants?
Most recruiting trials in Stamford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Stamford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Stamford?
The most common conditions under active study in Stamford include Breast Cancer (6), Anatomic Stage II Breast Cancer AJCC v8 (5), Obesity (5), Stage IV Lung Cancer AJCC v8 (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Stamford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Stamford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Stamford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Stamford?
Recruiting research sites in Stamford include Smilow Cancer Hospital Care Center at Long Ridge, Stamford Hospital/Bennett Cancer Center, Stamford Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Stamford right now?
The largest active categories in Stamford are Cancer & tumors (47), Neurology & pain (12), Diabetes & metabolic (8). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.